1.46
price down icon4.58%   -0.07
pre-market  Pre-mercato:  1.46  
loading
Precedente Chiudi:
$1.53
Aprire:
$1.48
Volume 24 ore:
2.23M
Relative Volume:
0.84
Capitalizzazione di mercato:
$283.71M
Reddito:
$314.00K
Utile/perdita netta:
$-40.23M
Rapporto P/E:
-5.2143
EPS:
-0.28
Flusso di cassa netto:
$-84.71M
1 W Prestazione:
-0.68%
1M Prestazione:
-7.01%
6M Prestazione:
+28.07%
1 anno Prestazione:
-20.65%
Intervallo 1D:
Value
$1.41
$1.54
Intervallo di 1 settimana:
Value
$1.41
$1.56
Portata 52W:
Value
$1.03
$2.565

Atai Life Sciences N V Stock (ATAI) Company Profile

Name
Nome
Atai Life Sciences N V
Name
Telefono
49 89 2153 9035
Name
Indirizzo
WALLSTRASSE 16, BERLIN
Name
Dipendente
54
Name
Cinguettio
Name
Prossima data di guadagno
2024-12-11
Name
Ultimi documenti SEC
Name
ATAI's Discussions on Twitter

Confronta ATAI con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ATAI
Atai Life Sciences N V
1.46 283.71M 314.00K -40.23M -84.71M -0.28
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
493.84 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
602.64 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
614.76 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
251.56 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
244.90 24.70B 3.81B -644.79M -669.77M -6.24

Atai Life Sciences N V Stock (ATAI) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-11-18 Reiterato H.C. Wainwright Buy
2024-04-03 Aggiornamento Maxim Group Hold → Buy
2022-11-01 Iniziato Loop Capital Buy
2021-11-30 Iniziato Maxim Group Buy
2021-11-11 Iniziato ROTH Capital Buy
2021-10-18 Iniziato H.C. Wainwright Buy
2021-09-01 Iniziato Jefferies Buy
2021-07-13 Iniziato Berenberg Buy
2021-07-13 Iniziato Canaccord Genuity Buy
2021-07-13 Iniziato Cantor Fitzgerald Buy
2021-07-13 Iniziato Citigroup Buy
2021-07-13 Iniziato Cowen Outperform
2021-07-13 Iniziato Credit Suisse Outperform
2021-07-13 Iniziato RBC Capital Mkts Sector Perform
2021-07-08 Iniziato Aegis Capital Buy
Mostra tutto

Atai Life Sciences N V Borsa (ATAI) Ultime notizie

pulisher
Apr 25, 2025

ATAI’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - investchronicle.com

Apr 25, 2025
pulisher
Apr 24, 2025

ATAI Life Sciences N.V [ATAI] stock for 65,560 USD was sold by Kirpekar Sahil - knoxdaily.com

Apr 24, 2025
pulisher
Apr 22, 2025

Investing in ATAI Life Sciences N.V (ATAI) might be an excellent idea, but the stock is currently overvalued/undervalued - uspostnews.com

Apr 22, 2025
pulisher
Apr 21, 2025

Atai Life Sciences: Pipeline And Regulatory Uncertainties Warrant Hold Rating - Seeking Alpha

Apr 21, 2025
pulisher
Apr 15, 2025

At What Point In Time Would I Choose To Purchase ATAI Life Sciences N.V (NASDAQ: ATAI) Stock? - stocksregister.com

Apr 15, 2025
pulisher
Apr 14, 2025

Psychedelic Drugs Market Future Business Opportunities - openPR.com

Apr 14, 2025
pulisher
Apr 08, 2025

Investor’s Delight: ATAI Life Sciences N.V (ATAI) Closes Weak at 1.27, Down -3.05 - DWinneX

Apr 08, 2025
pulisher
Apr 05, 2025

Berenberg starts atai Life Sciences coverage with Positive rating By Investing.com - Investing.com Australia

Apr 05, 2025
pulisher
Apr 04, 2025

Berenberg starts atai Life Sciences coverage with Positive rating - Investing.com

Apr 04, 2025
pulisher
Apr 02, 2025

Is Atai Life Sciences (ATAI) the Best German Stock to Buy According to Hedge Funds? - Insider Monkey

Apr 02, 2025
pulisher
Apr 01, 2025

ATAI Life Sciences N.V (ATAI) Slumps -5.99%, A Loss For Bears - Marketing Sentinel

Apr 01, 2025
pulisher
Mar 31, 2025

How Are Things Looking For ATAI Life Sciences N.V (NASDAQ: ATAI) For The Short Term? - stocksregister.com

Mar 31, 2025
pulisher
Mar 27, 2025

ATAI Life Sciences N.V (ATAI) Stock: A 52-Week Tale of Drops and Gains - investchronicle.com

Mar 27, 2025
pulisher
Mar 26, 2025

Insiders Make Huge Purchases of These 4 Biotech Stocks - 24/7 Wall St.

Mar 26, 2025
pulisher
Mar 25, 2025

Atai Life Sciences chief scientific officer sells $17,767 in shares By Investing.com - Investing.com India

Mar 25, 2025
pulisher
Mar 24, 2025

Atai Life Sciences CEO Rao Srinivas sells $101,814 in common shares By Investing.com - Investing.com South Africa

Mar 24, 2025
pulisher
Mar 24, 2025

Atai life sciences CMO Craig James sells $15,610 in shares By Investing.com - Investing.com South Africa

Mar 24, 2025
pulisher
Mar 24, 2025

Atai Life Sciences chief business officer sells $65,560 in stock By Investing.com - Investing.com South Africa

Mar 24, 2025
pulisher
Mar 24, 2025

Atai Life Sciences chief business officer sells $65,560 in stock - Investing.com India

Mar 24, 2025
pulisher
Mar 24, 2025

Atai Life Sciences CFO sells shares worth $45,285 - Investing.com India

Mar 24, 2025
pulisher
Mar 24, 2025

Atai life sciences CMO Craig James sells $15,610 in shares - Investing.com India

Mar 24, 2025
pulisher
Mar 24, 2025

Atai Life Sciences chief scientific officer sells $17,767 in shares - Investing.com

Mar 24, 2025
pulisher
Mar 24, 2025

Atai Life Sciences director Angermayer buys $2.52 million in shares By Investing.com - Investing.com UK

Mar 24, 2025
pulisher
Mar 24, 2025

Atai Life Sciences director Angermayer buys $2.52 million in shares - Investing.com

Mar 24, 2025
pulisher
Mar 24, 2025

Atai Life Sciences CEO Rao Srinivas sells $101,814 in common shares - Investing.com

Mar 24, 2025
pulisher
Mar 21, 2025

Psychedelic: atai Life Sciences, NRx report quarterly results - Yahoo Finance

Mar 21, 2025
pulisher
Mar 21, 2025

Nasdaq-Listed Biotech Firm Atai Life Sciences to Launch Bitcoin Treasury Strategy - Cryptonews

Mar 21, 2025
pulisher
Mar 20, 2025

ATAI Life Sciences invests $5M in Bitcoin as reserve asset By Investing.com - Investing.com Australia

Mar 20, 2025
pulisher
Mar 17, 2025

atai Life Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights - The Manila Times

Mar 17, 2025
pulisher
Mar 13, 2025

Psychedelic: atai reports dosing of first patient in Phase 2 VLS-01 trial - TipRanks

Mar 13, 2025
pulisher
Mar 11, 2025

atai Life Sciences Announces First Patient Dosed in Elumina, the Phase 2 Clinical Trial of VLS-01 for Treatment-Resistant Depression - Yahoo Finance

Mar 11, 2025
pulisher
Mar 04, 2025

Is Atai Life Sciences N.V. (ATAI) Among Stocks With At Least $20 Million In Insider Spending Recently? - Insider Monkey

Mar 04, 2025
pulisher
Mar 04, 2025

10 Stocks With At Least $20 Million In Insider Spending Recently - Insider Monkey

Mar 04, 2025
pulisher
Mar 03, 2025

How is ATAI’s stock performing after recent trades? - US Post News

Mar 03, 2025
pulisher
Mar 01, 2025

Atai Life Sciences N.V. (ATAI): Among the Best Psychedelic Stocks to Buy in 2025 - Insider Monkey

Mar 01, 2025
pulisher
Feb 28, 2025

12 Best Psychedelic Stocks to Buy in 2025 - Insider Monkey

Feb 28, 2025
pulisher
Feb 28, 2025

ATAI’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle

Feb 28, 2025
pulisher
Feb 27, 2025

Atai: Following The Path That Spravato Laid And Moving Beyond It - Seeking Alpha

Feb 27, 2025
pulisher
Feb 25, 2025

Comprehensive Market Analysis of Latest Published Different Types of Depression Reports | DelveInsight - GlobeNewswire Inc.

Feb 25, 2025
pulisher
Feb 24, 2025

atai Life Sciences to Participate in the TD Cowen 45th Annual Health Care Conference - Yahoo Finance UK

Feb 24, 2025
pulisher
Feb 23, 2025

Biotechs Highlight 6 Stocks Insiders Are Buying Now - 24/7 Wall St.

Feb 23, 2025
pulisher
Feb 20, 2025

Atai Life Sciences Raises $63.3 Million After Closing Public Offering -February 20, 2025 at 10:10 am EST - Marketscreener.com

Feb 20, 2025
pulisher
Feb 20, 2025

atai Life Sciences completes public offering, raising $63.25M - Proactive Investors UK

Feb 20, 2025
pulisher
Feb 20, 2025

atai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Common Shares - Yahoo Finance UK

Feb 20, 2025
pulisher
Feb 19, 2025

Apeiron Investment Group purchases $22.8m in ATAI Life Sciences shares By Investing.com - Investing.com Australia

Feb 19, 2025

Atai Life Sciences N V Azioni (ATAI) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.59
price up icon 0.24%
$69.69
price up icon 1.06%
$32.20
price up icon 0.53%
$23.46
price down icon 36.06%
$102.02
price down icon 15.36%
biotechnology ONC
$244.90
price down icon 4.40%
Capitalizzazione:     |  Volume (24 ore):